« Previous Next » Cancer Letters
Volume 318, Issue 1 , Pages 76-85 , 1 May 2012

Integrative genome-wide expression and promoter DNA methylation profiling identifies a potential novel panel of ovarian cancer epigenetic biomarkers

Brian S. Gloss
- Cancer Research Program, The Garvan Institute of Medical Research, Darlinghurst, New South Wales 2010, Australia
Kate I. Patterson
- Cancer Research Program, The Garvan Institute of Medical Research, Darlinghurst, New South Wales 2010, Australia
Caroline A. Barton
- Cancer Research Program, The Garvan Institute of Medical Research, Darlinghurst, New South Wales 2010, Australia
Maria Gonzalez
- Cancer Research Program, The Garvan Institute of Medical Research, Darlinghurst, New South Wales 2010, Australia
James P. Scurry
- Hunter Area Pathology Service, John Hunter Hospital, New Lambton, New South Wales 2310, Australia
Neville F. Hacker
- Gynaecological Cancer Centre, Royal Hospital for Women, Randwick, New South Wales 2031, Australia
Robert L. Sutherland
- Cancer Research Program, The Garvan Institute of Medical Research, Darlinghurst, New South Wales 2010, Australia
- St. Vincent’s Clinical School, Faculty of Medicine, University of New South Wales, New South Wales 2052, Australia
Philippa M. O’Brien
- Cancer Research Program, The Garvan Institute of Medical Research, Darlinghurst, New South Wales 2010, Australia
- St. Vincent’s Clinical School, Faculty of Medicine, University of New South Wales, New South Wales 2052, Australia
- Equal last authors.
Susan J. Clark
- Cancer Research Program, The Garvan Institute of Medical Research, Darlinghurst, New South Wales 2010, Australia
- St. Vincent’s Clinical School, Faculty of Medicine, University of New South Wales, New South Wales 2052, Australia
- Corresponding author. Address: Epigenetic Research Laboratory, Cancer Research Program, The Garvan Institute of Medical Research, 384 Victoria Street, Darlinghurst, New South Wales 2010, Australia. Tel.: +61 2 92958315; fax: +61 2 92958316.
- Equal last authors.